Contributing to the fight against eclampsia and anemia during pregnancy
January 2026 – December 2029
Senegal
Reducing maternal, neonatal, and infant mortality remains one of the most urgent health challenges in low- and middle-income countries. The United Nations (UN) ranks reducing maternal and infant mortality as the top sustainable development goal in health. Yet in many countries, progress has stalled. Most fatal complications occur during pregnancy, mainly due to four factors: obstetric hemorrhage, hypertensive disorders, maternal sepsis, and unsafe abortions.
It is estimated that:
– 46,000 maternal deaths
– More than 500,000 neonatal deaths and stillbirths are attributable each year to PE/E and hypertensive disorders.
– Approximately half of pregnant women suffer from anemia, which is associated with maternal and perinatal mortality, prematurity, preeclampsia, low birth weight, intrauterine growth restriction (IUGR), and cesarean delivery.
– There are approximately 2.3 million newborns and 1.9 million stillbirths each year.
Many of these deaths are preventable, and approximately 98% occur in low- and middle-income countries.
Beneficiaries
-
Pregnant women
-
Vulnerable and marginalized populations
-
Adolescent girls
-
People affected by climate change
-
Healthcare providers at all levels
-
Community members (male partners and other opinion leaders)
Results
-
R1 : Generating evidence on the feasibility, acceptability, and cost of comprehensive, context-appropriate, and women-centered care programs for EP/MA
-
R2 : Improved awareness, knowledge, and education about quality prenatal care services and improved models of care at the local, regional, and national levels
-
R3 : Maintaining the availability of key PE/MA products to support their nationwide rollout
-
R4 : Facilitating the adoption and use of PE/MA care models, including new and underutilized products
